VEGF-R2 as biomarker of angiogenesis in brain tumors 222
Breast cancer biomarkers 222
Biomarkers of breast cancer in breath 223
Biomarkers for breast cancer in nipple aspiration fluid 223
Circulating nucleic acid biomarkers of breast cancer 224
Flow cytometry for quantification of biomarker expression patterns 224
Plasma proteomics for biomarkers of breast cancer 224
Quantitative realtime PCR assays for biomarker validation 225
Cdk6 as a biomarker of breast cancer 225
Centromere protein-F 226
Carbonic anhydrase IX 226
COX-2 as a biomarker of breast cancer 226
Glycomic biomarkers of breast cancer 227
HER-2/neu oncoprotein 227
High mobility group protein A2 228
Hypermethylated genes as biomarkers of metastatic breast cancer 228
Lipocalin 2 as biomarker of breast cancer progression 229
Long intervening non-coding RNAs 229
Mammaglobin 229
miRNA biomarkers of breast cancer 230
p27 expression as biomarker for survival after chemotherapy 231
Podocalyxin 231
Progranulin as a biomarker of breast cancer 231
Proliferating cell nuclear antigen 231
Protein kinase C as a predictive biomarker of metastatic breast cancer 232
Retinoblastoma tumor suppressor gene as a biomarker 232
Riboflavin carrier protein 232
Risk of invasive cancer after diagnosis of ductal carcinoma in situ 233
Serum CA 15-3 as biomarker of prognosis in advanced breast cancer 233
Suppressor of deltex protein 233
Tumor microenvironment as biomarker of metastasis in breast cancer 234
Type III TGF-? receptor as regulator of cancer progression 234
Diagnostic tests based on breast cancer genes 234
Prognostic role of breast cancer genes 235
Protein biomarkers for breast cancer prevention 236
Biomarkers to evaluate efficacy of chemopreventio
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |